AMIFAMPRIDINE PHOSPHATE | N208078 | CATALYST PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
CATALYST PHARMACEUTICALS, INC. et al v. INVENTIA HEALTHCARE LIMITED 6 patentsANDA 218760amifampridine | D.N.J. | 2023-11-17 | Terminated 2024-08-01 | — |
Catalyst Pharmaceuticals, Inc. et al v. Lupin Ltd. et al 6 patentsANDA 217996amifampridine | D. Del. | 2023-03-02 | Terminated 2023-05-05 | — |
CATALYST PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS, INC. et al 6 patentsANDA 218029amifampridine | D.N.J. | 2023-03-01 | Terminated 2025-01-10 | — |
CATALYST PHARMACEUTICALS, INC. et al v. ANNORA PHARMA PRIVATE LIMITED et al 6 patentsANDA 218007amifampridine | D.N.J. | 2023-03-01 | Active | — |
CATALYST PHARMACEUTICALS, INC. et al v. LUPIN LTD. et al 6 patentsANDA 217996amifampridine | D.N.J. | 2023-03-01 | Terminated 2025-08-28 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).